Search results for "Type 1"

showing 10 items of 540 documents

Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.

2004

Clinically silent adrenocortical adenomas are the most frequent abnormalities in the adrenal gland. In contrast, adrenocortical carcinoma is a rare tumor with an extremely poor prognosis. The factors responsible for the frequent occurrence of benign adrenocortical tumors on one hand and the rare malignant transformation on the other are not known. Several genetic alterations such as loss of imprinting or loss of heterozygosity of the 11p15 gene locus causing a strong IGF-II overexpression have been demonstrated in the majority of adrenocortical carcinomas. In addition to IGF-II overexpression, increased levels of the IGF-I-receptor and IGFBP-2 have been found in advanced human adrenocortica…

Genetically modified mousemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryAdrenal Gland NeoplasmsLoss of HeterozygosityBiologymedicine.disease_causeBiochemistryMalignant transformationReceptor IGF Type 1Loss of heterozygosityInsulin-like growth factorMiceEndocrinologyInsulin-Like Growth Factor IIInternal medicineCell Line TumormedicineAdrenocortical carcinomaAnimalsHumansNeoplastic transformationNeoplastic ProcessesAdrenal glandChromosomes Human Pair 11Biochemistry (medical)CarcinomaGeneral Medicinemedicine.diseaseGene Expression Regulation NeoplasticInsulin-Like Growth Factor Binding Protein 2medicine.anatomical_structureEndocrinologyCarcinogenesisSignal TransductionHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
researchProduct

A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology

2015

Bone morphogenetic proteins (BMPs), members of the TGF-β superfamily, have numerous biological activities including control of growth, differentiation, and vascular development. Using an in vitro co-culture endothelial cord formation assay, we investigated the role of a BMP7 variant (BMP7v) in VEGF, bFGF, and tumor-driven angiogenesis. BMP7v treatment led to disruption of neo-endothelial cord formation and regression of existing VEGF and bFGF cords in vitro. Using a series of tumor cell models capable of driving angiogenesis in vitro, BMP7v treatment completely blocked cord formation. Pre-treatment of endothelial cells with BMP7v significantly reduced their cord forming ability, indicating …

Genetics and Molecular Biology (all)MaleVascular Endothelial Growth Factor AFibroblast Growth FactorAngiogenesisBone Morphogenetic Protein 7Nudelcsh:MedicineSmad ProteinsFibroblast growth factorBiochemistryNeovascularizationMiceCell Movementlcsh:ScienceBMP7 Angiogenesis TumorTumorMultidisciplinaryCell DeathNeovascularization PathologicMedicine (all)Cell migrationCell biologyEndothelial stem cellSettore MED/26 - NEUROLOGIAVascular endothelial growth factor ADrug CombinationsAdipose TissueAdipose Tissue; Animals; Bone Morphogenetic Protein 7; Cell Death; Cell Line Tumor; Cell Movement; Cell Proliferation; Collagen; Drug Combinations; Endothelial Cells; Fibroblast Growth Factor 2; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Laminin; Male; Mice Nude; Neoplastic Stem Cells; Neovascularization Pathologic; Neovascularization Physiologic; Proteoglycans; Receptor Fibroblast Growth Factor Type 1; Signal Transduction; Smad Proteins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)Neoplastic Stem CellsFibroblast Growth Factor 2ProteoglycansCollagenmedicine.symptomReceptorType 1Research ArticleSignal TransductionMice NudeNeovascularization PhysiologicBMP7BiologyCell LineSettore MED/04 - PATOLOGIA GENERALECell Line TumormedicineHuman Umbilical Vein Endothelial CellsAnimalsHumansAgricultural and Biological Sciences (all); Biochemistry Genetics and Molecular Biology (all); Medicine (all)Receptor Fibroblast Growth Factor Type 1PhysiologicNeovascularizationCell ProliferationPathologicMatrigelBiochemistry Genetics and Molecular Biology (all)lcsh:REndothelial CellsKinase insert domain receptorVascular Endothelial Growth Factor Receptor-2Xenograft Model Antitumor AssaysAgricultural and Biological Sciences (all)lcsh:QAngiogenesisLamininGlioblastomaPLoS ONE
researchProduct

Genetics of Polyglandular Failure

2010

Publisher Summary This chapter discusses the genetic aspects of polyglandular failure syndromes (APS).The polyglandular failure syndromes comprise of a wide spectrum of autoimmune disorders and encompass a rare juvenile type (APS1) and more frequent adult types (APS2 and APS3). The juvenile type APS1 is also known as autoimmune polyendocrinopathy candidiasis ectodermal dystrophy because it consists of three main disorders, namely chronic mucocutaneous candidiasis, autoimmune hypoparathyroidism and autoimmune Addison's disease. APS2 is defined as the association between Addison's disease and either autoimmune thyroid disease or type 1 diabetes mellitus and APS3 is characterized by the presen…

GeneticsType 1 diabetesendocrine system diseasesmedicine.diagnostic_testAutoimmune polyendocrinopathyDiseaseBiologymedicine.diseasePathophysiologyHypoparathyroidismImmunologymedicineChronic mucocutaneous candidiasisChromosome 21Genetic testing
researchProduct

Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk…

2021

Type 1 diabetes mellitus (T1DM) is associated with a high risk of cardiovascular (CV) complications, even after controlling for traditional CV risk factors. Therefore, determinants of the residual increased CV morbidity and mortality remain to be discovered. This prospective cohort of people living with T1DM in France (SFDT1) will include adults and children aged over six years living with T1DM, recruited throughout metropolitan France and overseas French departments and territories. The primary objective is to better understand the parameters associated with CV complications in T1DM. Clinical data and biobank samples will be collected during routine visits every three years. Data from conn…

GerontologyAdultBlood GlucoseEndocrinology Diabetes and MetabolismEndocrinologyQuality of lifeRisk FactorsDiabetes mellitusHealth careInternal MedicineMedicineHumansProspective StudiesProspective cohort studyChildSocioeconomic statusType 1 diabetesbusiness.industryBlood Glucose Self-MonitoringGeneral Medicinemedicine.diseaseBiobankDiabetes Mellitus Type 1Cardiovascular DiseasesHeart Disease Risk FactorsCohortbusinessDiabetesmetabolism
researchProduct

Continuous Glucose Monitoring in Type 1 Diabetes

2016

Background: Continuous glucose monitoring (CGM) patient systems have been shown to improve diabetes self-treatment when used consistently. The meaningful integration of this technology into everyday life, however, can vary greatly among CGM users and not all people with diabetes use CGM to its full potential. To address this issue, the study pursued 2 aims: first, to identify patient characteristics that underlie the acceptance of CGM in people with type 1 diabetes and, second, to examine the effects of different levels of experience with CGM use. Methods: Guided by a model based on the technology acceptance model (TAM), structural equation modeling (SEM) was employed to model the patient c…

GerontologyType 1 diabetesContinuous glucose monitoringbusiness.industryEndocrinology Diabetes and Metabolismmedia_common.quotation_subjectBiomedical Engineering030209 endocrinology & metabolismBioengineeringmedicine.diseaseStructural equation modeling03 medical and health sciences0302 clinical medicineFeelingDiabetes mellitusBlood Glucose Self-MonitoringInternal MedicinemedicineTechnology acceptance model030212 general & internal medicineEveryday lifebusinessSimulationmedia_commonJournal of Diabetes Science and Technology
researchProduct

73-COPING WITH TYPE 1 DIABETES: RESULTS OF THE GERMAN MULTICENTER DIABETES COHORT STUDY.

2004

GerontologyType 1 diabetesCoping (psychology)business.industryRetrospective cohort studymedicine.diseaselanguage.human_languageGermanPsychiatry and Mental healthClinical PsychologyDiabetes mellituslanguageMedicinebusinessProspective cohort studyCohort studyJournal of Psychosomatic Research
researchProduct

Diabetes mellitus tipo1: factores psicosociales y adaptación del paciente pediátrico y su familia. Revisión

2015

Type 1 diabetes mellitus is the most common chronic endocrine disease in children, with a very low incidence in the first months of life and reaching its peak during puberty (10-15 years old is the age group with the highest incidence at the time of onset). Based on the review of the scientific literature, our objective is to study the main psychosocial factors associated with the adjustment of these pediatric patients and their families. Research underscore the following risk factors: situational (stressful life events), personal (additional physical diseases, low self-esteem, emotional disturbances), and interpersonal (family breakdown and conflicts), and also protection factors (coping s…

GerontologyType 1 diabetesbusiness.industryIncidence (epidemiology)Psychological interventionmedicine.diseaseAffect (psychology)Developmental psychologySocial supportDiabetes mellitusPediatrics Perinatology and Child HealthHealth caremedicinebusinessPsychosocialArchivos Argentinos de Pediatria
researchProduct

The relevant role of family history in predicting type 2 diabetes occurrence.

2019

On June 6, 2019, the Polish Archives of Internal Medicine published an interesting article by Szczerbiński et al,1 entitled “Efficacy of family history, genetic risk score, and physical activity in assessing the prevalence of type 2 diabetes.” This editorial is a commentary on this paper, intending to highlight, one more time, the importance of a positive family history (FH+) of type 2 diabetes (T2D) for estimating diabetes occurrence in the adult population as well as the importance of physical activity (PA) for maintaining optimal body composition and a low incidence rate of chronic disease.2 Since 2011, my research group has provided periodical pieces of evidence (2011, 2013, and 2014) a…

Gerontologybusiness.industryPhysical activityMEDLINEType 2 diabetesmedicine.diseaseFamily History T2DM Exercise Physiology Physical Activity Health PromotionHealth promotionDiabetes Mellitus Type 1Diabetes Mellitus Type 2Risk FactorsDiabetes mellitusInternal MedicinePrevalenceMedicineHumansExercise physiologyFamily historybusinessExercisePolish archives of internal medicine
researchProduct

The diabetic cataract: an unusual presentation in a young subject: case report.

1997

This case report concerns a 14-year-old female patient, whose insulin-dependent diabetes mellitus was displayed by one infrequent complication, the cataract. This is an unusual manifestation in a 14-year-old patient; indeed, there are many findings in experimental animals demonstrating the development of this complication by maintaining blood glucose levels above 12 mM. After surgical therapy, complete vision was recovered, but we think that an earlier diagnosis and therapy of metabolic derangement of diabetes may have avoided this complication.

GlycosuriaBlood Glucosemedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismEye diseaseHypercholesterolemiaCataract ExtractionKetone BodiesCataractEndocrinologyGlycosuriaDiabetes mellitusFemale patientInternal MedicinemedicineHumansHypertriglyceridemiaMetabolic derangementbusiness.industrymedicine.diseaseDiabetic cataractSurgeryDiabetes Mellitus Type 1FemalePresentation (obstetrics)medicine.symptomComplicationbusinessJournal of diabetes and its complications
researchProduct

Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adul…

2010

Mesenchymal stem cells (MSC) are uniquely capable of crossing germinative layers borders (i.e. are able to differentiate towards ectoderm-, mesoderm- and endoderm-derived cytotypes) and are viewed as promising cells for regenerative medicine approaches in several diseases. Type I diabetes therapy should potentially benefit from such differentiated cells: the search for alternatives to organ/islet transplantation strategies via stem cells differentiation is an ongoing task, significant goals having been achieved in most experimental settings (e.g. insulin production and euglycaemia restoration), though caution is still needed to ensure safe and durable effects in vivo. MSC are obtainable in …

Graft RejectionCancer ResearchCellular differentiationCell Culture TechniquesClinical uses of mesenchymal stem cellsBiologyMesenchymal Stem Cell TransplantationRegenerative medicineUmbilical CordImmunomodulationMesenchymal stem cells Umbilical cord Wharton’s jelly Type 1 diabetes Beta cells Differentiation markers Pancreas development Inflammation Immune modulation HypoimmunogenicityInsulin-Secreting CellsWharton's jellyAnimalsHumansRegenerationEmbryonic Stem CellsSettore BIO/16 - Anatomia UmanaRegeneration (biology)Mesenchymal stem cellCell DifferentiationMesenchymal Stem CellsCell BiologyAntigens DifferentiationTransplantationAdult Stem CellsDiabetes Mellitus Type 1Adipose TissueImmunologyCancer researchCord Blood Stem Cell TransplantationStem cellStem Cell Reviews and Reports
researchProduct